|
|
|
|
|
|
|
|
|
Sanofi-Synthelabo - Division Sale
14/04/2004
GlaxoSmithKline has acquired two heart disease drugs from Sanofi-Synthelabo for £297m, including a manufacturing facility in France that employs 650 staff
Subscribe now to get advanced acquisition search capabilities.
| Business for Sale Search
|
|
|
|
|
|
|
|
|
© 1995-2009 Business Sale Report. A division of Business Data International Ltd. All rights reserved
|